Cetera Investment Advisers Ishares Tr Genomics Immunology Transaction History

Cetera Investment Advisers

  • $41.3 Billion
  • Q1 2024

A detailed history of Cetera Investment Advisers transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Cetera Investment Advisers holds 13,334 shares of IDNA stock, worth $304,815. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,334
Holding current value
$304,815
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 24, 2024
BUY
$22.28 - $25.2 $297,081 - $336,016
13,334 New
13,334 $321,000
Q2 2021

Aug 13, 2021
SELL
$43.63 - $52.03 $236,125 - $281,586
-5,412 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$42.64 - $54.83 $12,152 - $15,626
-285 Reduced 5.0%
5,412 $247,000
Q4 2020

Feb 17, 2021
BUY
$37.93 - $50.1 $216,087 - $285,419
5,697 New
5,697 $262,000

Others Institutions Holding IDNA

# of Institutions
66
Shares Held
1.84M
Call Options Held
0
Put Options Held
0
View Full List

About ISHARES TR GENOMICS IMMUNOLOGY

IDNA Quotes by TradingView
  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email